UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates

Nature communications, 2021-03, Vol.12 (1), p.1346-1346, Article 1346

2021

Volltextzugriff (PDF)

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Cell, 2020-09, Vol.182 (5), p.1284-1294.e9

2020

Volltextzugriff (PDF)

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Nature (London), 2022-02, Vol.602 (7898), p.657-663

2022

Volltextzugriff (PDF)

Current status on the development of pseudoviruses for enveloped viruses

Reviews in medical virology, 2018-01, Vol.28 (1), p.n/a

2018

Volltextzugriff (PDF)

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

Nature protocols, 2020-11, Vol.15 (11), p.3699-3715

2020

Volltextzugriff (PDF)

High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients

The Journal of infection, 2020-09, Vol.81 (3), p.420-426

2020

Volltextzugriff (PDF)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines

Cell research, 2021-07, Vol.31 (7), p.732-741

2021

Volltextzugriff (PDF)

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Nature (London), 2020-08, Vol.584 (7819), p.120-124

2020

Volltextzugriff (PDF)

Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2

Nature communications, 2021-07, Vol.12 (1), p.4210-12, Article 4210

2021

Volltextzugriff (PDF)

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Cell, 2021-04, Vol.184 (9), p.2362-2371.e9

2021

Volltextzugriff (PDF)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

Emerging microbes & infections, 2022-12, Vol.11 (1), p.1-5

2022

Volltextzugriff (PDF)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

Science (American Association for the Advancement of Science), 2020-09, Vol.369 (6510), p.1505-1509

2020

Volltextzugriff (PDF)

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

Nature (London), 2022-08, Vol.608 (7923), p.593-602

2022

Volltextzugriff (PDF)

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Emerging microbes & infections, 2020-01, Vol.9 (1), p.680-686

2020

Volltextzugriff (PDF)

The molecular basis for SARS-CoV-2 binding to dog ACE2

Nature communications, 2021-07, Vol.12 (1), p.4195-4195, Article 4195

2021

Volltextzugriff (PDF)

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

Nature communications, 2021-08, Vol.12 (1), p.5000-5000, Article 5000

2021

Volltextzugriff (PDF)

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys

Nature communications, 2020-11, Vol.11 (1), p.5752-5752, Article 5752

2020

Volltextzugriff (PDF)

Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy

Cell, 2020-11, Vol.183 (4), p.1013-1023.e13

2020

Volltextzugriff (PDF)

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

Nature (London), 2022-03, Vol.603 (7903), p.919-925

2022

Volltextzugriff (PDF)

Detection and assessment of infectivity of hepatitis E virus in urine

Journal of hepatology, 2016-01, Vol.64 (1), p.37-43

2016

Volltextzugriff (PDF)

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

Cell research, 2022-03, Vol.32 (3), p.269-287

2022

Volltextzugriff (PDF)

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants

Cell research, 2021-10, Vol.31 (10), p.1130-1133

2021

Volltextzugriff (PDF)

Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients

Signal transduction and targeted therapy, 2021-09, Vol.6 (1), p.346-346, Article 346

2021

Volltextzugriff (PDF)

Neutralization potency of the 2023-24 seasonal influenza vaccine against circulating influenza H3N2 strains

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2380111

2024

Volltextzugriff (PDF)

SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review

Vaccines (Basel), 2024-05, Vol.12 (5), p.554

2024

Volltextzugriff (PDF)

1 – 25 von 384

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(349)
Mit Volltextzugriff
(347)

Publikationsform

Sprache

Englisch
(377)
Chinesisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(303)
Life Sciences & Biomedicine
(200)
Humans
(120)
Animals
(77)
Severe Acute Respiratory Syndrome Coronavirus 2
(63)
Technology
(62)
Physical Sciences
(53)
Science & Technology - Other Topics
(51)
Vaccines
(51)
Covid-19
(48)
Immunology
(48)
Sars-Cov-2
(46)
Antibodies
(45)
Infectious Diseases
(44)
Mice
(44)
Microbiology
(44)
Virology
(44)
Viruses
(43)
Coronaviruses
(41)
Female
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Emerging Microbes & Infections
(21)
Journal Of Medical Virology
(21)
Signal Transduction And Targeted Therapy
(10)
Nature
(8)
Nature Communications
(8)
Scientific Reports
(8)
Cell Discovery
(7)
Frontiers In Immunology
(6)
Plos One
(6)
Virologica Sinica
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Current status on the development of pseudoviruses for enveloped viruses

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

The molecular basis for SARS-CoV-2 binding to dog ACE2

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys

Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

Detection and assessment of infectivity of hepatitis E virus in urine

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants

Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients

Neutralization potency of the 2023-24 seasonal influenza vaccine against circulating influenza H3N2 strains

SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review

Suchergebnisse filtern